Skip to main content

1 Result(s)

within Mingnan Cao Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis

    There are increasing data on the potential risk of pancreatic carcinoma associated with glucagon-like peptide 1 receptor agonists (GLP-1RAs).

    Mingnan Cao, Chen Pan, Yue Tian, Li Wang… in International Journal of Clinical Pharmacy (2023)